We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$383M
AUM Growth
-$51.9M
Cap. Flow
-$65M
Cap. Flow %
-16.98%
Top 10 Hldgs %
21.34%
Holding
731
New
218
Increased
59
Reduced
110
Closed
344

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.03M
2
AAPL icon
Apple
AAPL
+$8.95M
3
MRNA icon
Moderna
MRNA
+$7.35M
4
GS icon
Goldman Sachs
GS
+$5.62M
5
XYZ
Block Inc
XYZ
+$5.37M

Sector Composition

Rank Sector Weight
1 Technology 18.65%
2 Consumer Discretionary 18.29%
3 Consumer Staples 10.44%
4 Healthcare 10.32%
5 Industrials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLI icon
151
State Street Industrial Select Sector SPDR ETF
XLI
$33.4B
$655K 0.17%
+6,400
New +$656K
CGNX icon
152
Cognex
CGNX
$10.2B
$654K 0.17%
7,785
+2,185
+39% +$177K
GTM
153
ZoomInfo Technologies
GTM
$908M
$651K 0.17%
+12,483
New +$587K
VTI icon
154
Vanguard Total Stock Market ETF
VTI
$655B
$646K 0.17%
+2,900
New +$629K
CZR icon
155
Caesars Entertainment
CZR
$6.1B
$643K 0.17%
+6,200
New +$626K
ARKK icon
156
ARK Innovation ETF
ARKK
$5.74B
$641K 0.17%
4,900
-16,900
-78% -$1.97M
TMUS icon
157
T-Mobile US
TMUS
$190B
$637K 0.17%
4,400
-31,600
-88% -$4.36M
QSR icon
158
Restaurant Brands International
QSR
$25.8B
$627K 0.16%
+9,724
New +$655K
DOX icon
159
Amdocs
DOX
$5.64B
$626K 0.16%
8,087
-2,663
-25% -$206K
PLTR icon
160
Palantir
PLTR
$315B
$626K 0.16%
23,750
-123,300
-84% -$2.85M
TS icon
161
Tenaris
TS
$28.5B
$626K 0.16%
+28,605
New +$647K
EMR icon
162
Emerson Electric
EMR
$83.6B
$618K 0.16%
+6,417
New +$603K
QTS
163
DELISTED
QTS REALTY TRUST, INC.
QTS
$617K 0.16%
+7,981
New +$542K
PM icon
164
Philip Morris
PM
$305B
$615K 0.16%
+6,204
New +$595K
CPRI icon
165
Capri Holdings
CPRI
$1.82B
$612K 0.16%
10,700
-9,700
-48% -$528K
CERN
166
DELISTED
Cerner Corp
CERN
$601K 0.16%
+7,683
New +$591K
AMAT icon
167
Applied Materials
AMAT
$410B
$598K 0.16%
4,200
-11,169
-73% -$1.5M
KRE icon
168
State Street SPDR S&P Regional Banking ETF
KRE
$4.47B
$594K 0.16%
+9,060
New +$619K
BSX icon
169
Boston Scientific
BSX
$67.6B
$590K 0.15%
13,789
-24,611
-64% -$1.04M
CMA
170
DELISTED
Comerica
CMA
$585K 0.15%
8,204
+4,004
+95% +$297K
TRP icon
171
TC Energy
TRP
$71.2B
$585K 0.15%
11,822
-15,378
-57% -$769K
ROST icon
172
Ross Stores
ROST
$78.1B
$583K 0.15%
+4,700
New +$586K
ATKR icon
173
Atkore
ATKR
$2.54B
$582K 0.15%
+8,200
New +$624K
AN icon
174
AutoNation
AN
$7.1B
$565K 0.15%
5,963
-3,903
-40% -$382K
IVZ icon
175
Invesco
IVZ
$13.3B
$564K 0.15%
+21,109
New +$575K

Similar funds

Bayesian Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Bayesian Capital Management held 731 positions worth $383M, down 12% from $435M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Bayesian Capital Management withdrew a net $65M in Q2 2021, closing 344 positions and reducing 110 holdings. Its most notable exit was Microsoft, an estimated $9.03M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Bayesian Capital Management opened a new position in General Mills worth $11M.

  • Bayesian Capital Management's largest Q2 2021 buy was General Mills: 180,673 shares worth $11M.
  • Bayesian Capital Management added most to Amazon in Q2 2021, an estimated $7.31M increase.
  • Bayesian Capital Management's biggest Q2 2021 reduction was Apple, cutting an estimated $8.95M.
  • Bayesian Capital Management fully exited Microsoft in Q2 2021, selling an estimated $9.03M.
  • Bayesian Capital Management's ten largest holdings make up 21% of its $383M portfolio in Q2 2021.
  • Bayesian Capital Management opened 218 new positions and closed 344 in Q2 2021.
  • Bayesian Capital Management's portfolio value fell 12% quarter-over-quarter to $383M.

Based on Bayesian Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.